This inventor holds 1 USPTO granted patent. Top assignee: Molecure S.a.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovator Spotlight: Nazan Cemre GÜNER-Chalimoniuk
Introduction
Nazan Cemre GÜNER-Chalimoniuk is a prominent inventor based in Laz, Poland. She has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutics targeting arginase activity. Her innovative work has the potential to impact various diseases associated with arginase.
Latest Patents
GÜNER-Chalimoniuk holds a patent for "Arginase inhibitors and methods of use thereof." This inventive compound is a small molecule therapeutic that serves as a potent inhibitor of arginase 1 and arginase 2 activity. The invention also includes pharmaceutical compositions comprising these compounds, along with methods for their use in treating or preventing diseases linked to arginase activity. She has 1 patent to her name.
Career Highlights
Nazan is currently associated with Molecure S.A., where she continues to advance her research and development efforts. Her work at the company focuses on creating innovative solutions in the pharmaceutical industry.
Collaborations
Throughout her career, GÜNER-Chalimoniuk has collaborated with notable colleagues, including Anna Gzik and Jacek Chrzanowski. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Nazan Cemre GÜNER-Chalimoniuk is a trailblazer in the field of pharmaceutical innovation. Her work on arginase inhibitors showcases her commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile